Patients with hypoplastic left heart syndrome undergo a series of operations to separate the pulmonary and systemic circulations. The first of at least 3 operations occurs in the newborn period, with a stage I palliation. The goal of stage I palliation is to provide pulmonary blood flow and create an unobstructed systemic outflow tract. Advances in surgical techniques and intraoperative and postoperative care have helped decrease morbidity and mortality for patients with hypoplastic left heart syndrome who have the stage I Norwood operation, but the patients continue to be at increased risk for hemodynamic collapse and adverse outcomes. This article discusses risk factors, surgical approach, postoperative nursing and medical management strategies, differences between and outcomes for the Norwood operation with the right ventricle to pulmonary artery conduit and the Norwood operation with a modified Blalock-Taussig shunt. (Critical Care Nurse. 2016; 36[6]:42-51) Dorothy M. Beke, RN, MS, CPNP-PC/AC
In this article, I focus on stage I palliation for HLHS with either the Norwood procedure with the right ventricle to pulmonary artery (RVPA) conduit or the Norwood procedure with a modifi ed Blalock-Taussig shunt (mBTS). I discuss risk factors, variations in surgical approach, postoperative nursing and medical management, differences between the 2 shunt types, and a comparison of outcomes for the Norwood operation.
Historical Perspective
In 1981, Norwood et al 3 described the use of valved and nonvalved RVPA conduits, among other approaches to establish pulmonary blood fl ow (PBF), for stage I palliation of HLHS in a series of patients who had surgical repair. This early group of patients, including those who had RVPA conduits established, had an overall mortality rate of 79%. Then in 1983, Norwood et al 4 reported a successful outcome with a staged surgical approach for treatment of HLHS. A central shunt between the aorta and branch pulmonary arteries was used to provide PBF for the fi rst stage of palliation. 4 Later the central aorta to pulmonary artery shunt was replaced with an mBTS, from the subclavian artery to the right pulmonary artery. 4 This method became the preferred one for providing a controlled source of PBF in the Norwood operation. 4 Modifi cations to the original surgical approach, including use of an mBTS, became widely adopted as the standard approach to surgical palliation.
Kishimoto et al 5 reintroduced the RVPA conduit for surgical palliation with a valved conduit. In 2003 Sano et al 6 described the use of smaller, nonvalved, 4-or 5-mm polytetrafl uoroethylene conduits to provide PBF as part of the Norwood operation with improved stage I survival, (53%-89%). Since then, the Norwood procedure with an RVPA conduit, sometimes referred to as a Sano modifi cation, has been accepted by many centers for initial palliation of HLHS and is associated with improved survival (74% vs 64% for the mBTS) at 12 months. 7 Despite advances and modifications in palliation of single-ventricle disease, substantial differences have been reported in choice of palliation (including Norwood with mBTS vs RVPA conduit, or the hybrid approach), intraoperative technique 8 (type of RVPA shunt, perfusion techniques), and postoperative management strategies (eg, types of inotropes and vasodilating agents used) 9 among numerous institutions in which a Norwood procedure is used. Pasquali et al 10 reported that among 53 institutions in which the Norwood operation was used, survival varied by 14%, and overall in-hospital mortality was 22%. An analysis by Baker-Smith et al 9 of the Society of Thoracic Surgeons Congenital Heart Database indicated that development of renal and cardiovascular complications posed the greatest risk to survival. Risk factors for early, in-hospital mortality after stage I palliation are listed in Table 1 .
Surgical Approach
Surgical techniques for performing the Norwood operation with either type of shunt vary from center to center. Regional cerebral perfusion is widely used in the operation at many centers, although some institutions prefer a brief period of deep hypothermic cardiac arrest. 16 Regional cerebral perfusion is commonly used to limit total body circulatory arrest during aortic arch repairs, [11] [12] [13] [14] Prematurity [11] [12] [13] Mechanical circulatory support before surgery 11, 12 Dominant right ventricle 11, 12 Low birth weight or weight < 2.5 kg 11, 13, 14 Unbalanced atrioventricular canal defect diagnosis 13 Preoperative shock 11 Mitral stenosis-aortic atresia variant of hypoplastic left heart syndrome 15 Open sternum immediately after surgery 14 Increased duration of deep hypothermic cardiac arrest 14 Postoperative renal dysfunction 14 The surgical procedure usually includes division of the patent ductus arteriosus; division of the main pulmonary artery; the Damus-Kaye-Stansel procedure to join the aorta to the main pulmonary artery, along with an extended aortic arch augmentation and coarctectomy; and construction of a source for PBF. 16 When the RVPA conduit is used for PBF, the nonvalved conduit is inserted from the ventricle to the distal stump of the pulmonary trunk. The proximal end of the conduit is placed by using a right ventriculotomy incision ( Figure 1 ). Transmural insertion of an externally reinforced conduit allows for a ring-enforced, polytetrafl uoroethylene, nonvalved RVPA conduit, usually 5 mm in diameter, to be "inserted like a straw" transmurally into the right ventricle with a limited ventriculotomy incision. 18 The ring-reinforced conduit has been associated with decreased incidence of proximal conduit obstruction and interstage interventions and with greater pulse pressures and improved pulmonary artery growth before a stage II operation. 19 When the mBTS is used to establish PBF, a nonvalved polytetrafl uroethylene conduit as small as 3 mm, although usually 3.5 to 4 mm, is placed from the innominate or subclavian artery to the right pulmonary artery (Figure 2 ). The weight of the patient determines the size of the pulmonary shunt used for either the RVPA conduit or the mBTS. Use of the optimal shunt size aids in minimizing the postoperative effects of increased PBF at the expense of systemic circulation. 20 Good technical outcomes after a Norwood operation require ensuring an unobstructed pulmonary venous return by creating a nonrestrictive intra-atrial communication, unobstructed systemic outfl ow through the coronary arteries and aortic arch via the Damus-Kaye-Stansel anastomosis, and adequate controlled PBF. 21 In addition to good technical outcomes, decreasing morbidity and improving survival with excellent postoperative management are required.
Goals of Postoperative Management
The goals of stage I palliation with a Norwood operation include balancing pulmonary-to-systemic circulation and providing adequate cardiac output for tissue oxygenation and perfusion until the infant is ready for a stage II palliation with a bidirectional Glenn or a hemi-Fontan procedure. 20 Strategies to achieve the goals include maximizing the ratio of systemic oxygen delivery to oxygen extraction. Maximizing the ratio depends on using the appropriate pulmonary shunt size, managing the ratio of pulmonary to systemic perfusion (Qp:Qs) and oxygenation, and maintaining unobstructed coronary and systemic perfusion in the postoperative period. 21 Ideally, a Qp:Qs of approximately 1:1 is optimal. Qp:Qs can be calculated by using the Fick principle 22 ( Table 2) . Although the Fick principle is commonly used to assess the balance of Qp:Qs, the results may not be accurate in determining the absolute ratio if the actual pulmonary venous saturation is an assumed value. As a result, calculation of Qp:Qs should only be used in conjunction with bedside assessment, including a nurse's evaluation of hemodynamic status, perfusion, and other indicators of cardiac function.
Postoperative Nursing Assessment and Interventions

General Management
Improved monitoring and prompt intervention after stage I palliation can signifi cantly decrease early mortality in high-risk patients. 23 Nursing and medical management should focus on optimizing pulmonary and systemic perfusion while maintaining adequate cardiac output. Managing excessive PBF in the postoperative period, most often a challenge associated with the mBTS, has traditionally required inducing respiratory acidosis via ventilatory maneuvers, including decreasing minute ventilation, and by decreasing the fraction of inspired oxygen. 20, 21 Decreasing minute ventilation and the fraction of inspired oxygen may increase pulmonary vascular resistance (PVR) and thereby reduce PBF. However, the most critical variable with the greatest impact on PBF is the shunt size, not pharmacological or ventilatory strategies to increase PVR. 20, 21 Excessive measures to increase PVR may lead to pulmonary venous desaturation, resulting in decreased oxygen delivery if not compensated for with an increase in cardiac output. 21 Manipulation of PVR alone should be avoided because it increases the risks for cardiac arrest and early mortality. Patients may be at higher risk for adverse events, such as vagal stimulation related to suctioning of endotracheal tubes, and loss of functional residual capacity. Adequate analgesia and sedation to reduce stimulation and stress, and ventilation by hand to ensure adequate functional residual capacity before suctioning should be carefully considered when suctioning of an endotracheal tube is required.
Nursing interventions include providing adequate analgesics and sedatives and avoiding hyperventilation, which may increase PBF and markedly reduce systemic output. Persistent excessive PBF in the preoperative period predisposes patients to pulmonary hypertensive crisis and subsequent worsening of clinical status in the postoperative phase. 24 Interventions to manipulate systemic vascular resistance (SVR) are a more reliable way of ensuring good cardiac output and balancing Qp:Qs. 20, 21 Low cardiac output, an increase in SVR, and myocardial dysfunction often occur after surgery. Measures to decrease SVR in the postoperative period are of paramount importance. Systemic afterload can be augmented by using medications such as milrinone, sodium nitroprusside, phentolamine (a reversible, nonselective -adrenergic blocker used during the intraoperative period), or phenoxybenzamine. Phenoxybenzamine, although not approved by the Food and Drug Administration, is a nonselective, irreversible -adrenergic blocking agent with a long half-life that may be effective in improving systemic oxygen delivery and outcomes in patients in the postoperative period. 25 Other inotropic agents such as dopamine and epinephrine may be indicated to balance the effects of afterload-reducing agents. Vasopressin is the drug of choice to counteract the effects of excessive vasodilatation induced by phenoxybenzamine.
Nursing and medical assessment includes vigilant monitoring of vital signs, hemodynamic parameters, waveforms, and cardiac rhythms while ensuring optimal acid-base balance and adequate preload, afterload, and systemic perfusion 26 (Table 3 ). Assessment includes evaluation of blood pressure, central fi lling pressures, peripheral warmth and perfusion, pulses, capillary refi ll, hourly volume status, and urine output, (minimum approximately 0.5-1 mL/kg per hour 36 ). The bedside nurse is responsible for monitoring hematologic values and for replacing blood and fl uid loss with the appropriate blood products and volumes as indicated. Maintaining a hematocrit of 40% to 50% may optimize systemic oxygen delivery. 20 Diligent monitoring of temperature is of paramount importance in the postoperative period, and measures should be taken to avoid both hypothermia, which can interfere with clotting and increase PVR and SVR, and hyperthermia. A temperature greater than 37°C (98.6°F) exacerbates tachyarrhythmias, decreases the seizure threshold, and increases myocardial work and oxygen consumption, predisposing the patient to hemodynamic compromise. 37 Measures to decrease metabolic demand and stress include temperature control (~36°C-37°C [~96.8°F-98.6°F]), mechanical ventilation, steps to minimize pulmonary reactivity, and adequate levels of analgesia and sedation. Physiological parameters (tachycardia, hypertension, oxygen desaturation) and developmentally appropriate sedation and pain tools are required to appropriately manage pain and distress. 38 
Detection and Management of Early Worsening in Clinical Status
Early indicators of inadequate systemic perfusion and low cardiac output include tachycardia, hypotension, decreased urine output, inadequate systemic perfusion, elevated temperature, low mixed venous oxygen saturation (SvO 2 ), and increased serum levels of lactate. 30, 31 A low SvO 2 via the superior vena cava with a widening difference in arterial and venous oxygen saturation greater than 25% to 30% and increasing levels of serum lactate may be ominous signs of impending cardiovascular collapse. [33] [34] [35] A low SvO 2 indicates a mismatch of tissue oxygen delivery and demand and increased oxygen extraction. As this mismatch worsens, decreased tissue oxygen delivery and anaerobic metabolism result in lactic acidosis. An increase in the serum level of lactate indicates inadequate peripheral perfusion and is a predictor of mortality. [33] [34] [35] The risk of anaerobic metabolism is increased signifi cantly when SvO 2 is less than 30%. 30 Hoffman et al 30 found that targeting an SvO 2 of 50% after the Norwood procedure was the most important clinical parameter in decreasing early mortality. Monitoring with near-infrared spectroscopy may be helpful to follow trends in SvO 2 . Early detection and intervention for decreased cardiac output and afterload-reducing strategies have been correlated with better outcomes and decreased mortality. 23, 31 Other signs of low cardiac output are metabolic acidosis, tachycardia, oliguria, and hypotension.
Further diagnostic evaluation for indications of low cardiac output should be instituted early when indicated. Echocardiography is used to determine potential causes of low output, including atrioventricular valve regurgitation, aortic arch obstruction, aortic regurgitation, decreased ventricular function, pericardial effusion, and a restrictive atrial septum (Table 4) . Reoperation or other interventions for residual anatomic lesions causing low cardiac output should be carefully considered to decrease morbidity and mortality after the Norwood operation.
Management of Acute Shunt Obstruction
Acute shunt obstruction may occur in patients undergoing the Norwood operation with an mBTS. The obstruction is usually due to an occlusive thrombus in the shunt. The initial signs usually include acute refractory hypoxemia and decreased end-tidal carbon dioxide in patients receiving mechanical ventilation. Severe hypoxemia due to shunt obstruction can lead to cardiovascular collapse. Acute shunt obstruction is usually managed by adjustments in the fraction of inspired oxygen, volume expansion, and administration of a heparin bolus to avoid further thrombus formation. Stabilization with extracorporeal membrane oxygenation may be necessary until the shunt obstruction can be relieved with interventional cardiac catheterization or reoperation. Patients with shunted single-ventricle physiology who require mechanical circulatory support for hypoxia related to acute shunt thrombosis have better outcomes than do patients who require extracorporeal membrane oxygenation predominantly for hypotension leading to cardiac arrest. 39, 40 Acute shunt obstruction due to thrombosis is rare with the RVPA shunt because to-and-fro flow via the conduit decreases the likelihood of clot formation.
Nutrition
Malnutrition and inadequate growth are common in infants with HLHS after initial surgical palliation. 41, 42 Optimizing caloric intake often begins with the initiation of total parenteral nutrition early in the postoperative period, with a goal of 90 to 100 kcal/kg per day. 43 Fluid intake should be adjusted to at least 100 mL/kg per day on postoperative day 1 to maximize nutritional intake. 43 Enteral feedings should be initiated early when the patient shows indications of adequate systemic output (low serum level of lactate, sufficient urine output, and good peripheral perfusion), with a goal of 120 to 150 kcal/kg per day. 43, 44 Optimal weight gain is 20 to 30 g/d. 43 Nursing assessment includes monitoring feeding tolerance, nutritional intake, and daily calorie counts. The use of feeding algorithms can be both beneficial and safe in advancing nutritional intake in patients with HLHS. 43, 45 Care of the Patient's Family Parents experience considerable stress throughout the hospitalization of their child, regardless of severity of illness. 46 Parents may feel most supported when they receive honest communication and ongoing delivery of information about their child's clinical course from the interdisciplinary team. 47, 48 Nurses are central in providing emotional support and timely information, helping families navigate unfamiliar settings and circumstances, and encouraging family members to participate in care whenever possible.
Norwood Procedure With RVPA Conduit and Norwood Procedure With mBTS
The Norwood procedure with an mBTS results in continuous forward flow into the pulmonary artery in both systole and diastole, causing diastolic retrograde flow into the aorta and coronary arteries. In contrast, the Norwood procedure with an RVPA conduit allows greater balance of pulmonary-to-systemic circulation in the postoperative period. Unlike the situation with an mBTS, with the RVPA conduit, no diastolic steal from runoff of blood from the aorta to the pulmonary circuit occurs. As a result, diastolic blood pressure is generally higher and pulse pressure is narrower. 49, 50 This situation allows improved coronary and end-organ perfusion because the coronary arteries are perfused in diastole.
Palliation with the RVPA shunt usually results in free pulmonary regurgitation via the conduit that may decrease net PBF because pulmonary circulation occurs solely in systole via the conduit. The decrease in net PBF may result in lower oxygen saturation. Decreased oxygenation may lead to reduced respiratory reserve and then greater cyanosis with any coexisting lung disease. Increased cyanosis also occurs with increases in somatic growth. The RVPA conduit may predispose patients to decreased growth of the distal pulmonary artery because of the decreased PBF.
in patients with single-ventricle congenital heart disease treated with the Norwood operation regardless of the shunt type. However, these issues may be of particular concern for patients who have the Norwood procedure with the mBTS because of the larger ventricular volume loading from diastolic runoff through the shunt.
Stenosis or obstruction in the shunt, branch pulmonary arteries, or neoaorta requiring intervention have been reported more often in patients with the RVPA conduit than in patients with the mBTS. 7,51,52 A known complication of the RVPA conduit is proximal conduit stenosis, although the incidence most likely will be decreased with the use of newer surgical techniques and use of a ringed conduit. 18, 19, 53, 54 The ventriculotomy incision associated with placement of the RVPA conduit may lead to ventricular dysfunction, arrhythmias, and, possibly, aneurysm formation. The long-term effects of a ventriculotomy are still unknown. Patients with the RVPA conduit most likely will require an earlier stage II operation because of increased cyanosis 55, 56 (Table 5 ). In comparison with the RVPA conduit, the mBTS allows diastolic steal, which may lead to lower diastolic blood pressure, widened pulse pressure, and decreased coronary perfusion. The mBTS allows excessive pulmonary perfusion because blood fl ow to the pulmonary circuit from the aorta occurs during both systole and diastole. Volume load to a single ventricle may result in marked congestive heart failure and poor somatic growth, predisposing the patient to earlier stage II palliation (Table  5) . Although the Norwood procedure with an RVPA conduit has generally been accepted as the standard operation for HLHS in many centers, 7 stage I palliation with the mBTS may be indicated for neonates who have a restrictive atrial septum (resulting in obstructed pulmonary venous return, high PVR, lung injury, and increased cyanosis) and in patients with a single left ventricle in whom a ventriculotomy incision is avoided.
Investigators in the Single Ventricle Reconstruction trial, a randomized study at 15 North American centers by the Pediatric Heart Network, compared the Norwood procedure with the mBTS and the Norwood procedure with the RVPA conduit. 7 Transplant-free survival with the RVPA conduit was greater at 12 months than was survival with the mBTS; the greatest number of deaths occurred during the interstage period (from discharge after stage I palliation to a stage II operation), before a bidirectional Glenn or hemi-Fontan procedure. 7 Although mortality was decreased, more unplanned cardiovascular interventions were associated with the RVPA conduit than with the mBTS. Furthermore, the differences between the 2 groups were not significant for right ventricle size and function at 14 months, nonfatal serious adverse events at 12 months, and transplant-free survival after 12 months. 7 Several secondary outcomes of the trial included additional fi ndings related to early The mBTS allows diastolic steal, which may lead to lower diastolic blood pressure, widened pulse pressure and decreased coronary perfusion.
were significantly associated with greater severity of illness and patient factors, including genetic anomalies, decreased birth weight, and lower maternal education. A 3-year follow-up 61 of the Single Ventricle Reconstruction trial revealed no transplant-free survival benefit associated with an RVPA conduit as compared with an mBTS. Compared with patients with an mBTS, patients with an RVPA conduit had a slightly decreased right ventricular ejection fraction, an increase in heart rate as they grew older, a greater number of cardiovascular interventional procedures, and an increased hazard ratio as time progressed.
61
Conclusion
Patients undergoing the stage I Norwood procedure are at risk for labile hemodynamic status and adverse events, including cardiac arrest. Postoperative management requires balancing Qp:Qs, reducing SVR, optimizing systemic oxygen delivery, avoiding increased PBF with excessive mechanical ventilation, enhancing myocardial contractility, treating low cardiac output immediately, monitoring of SvO 2 and serum lactate levels, and promptly evaluating and correcting residual anatomical lesions (eg, aortic arch obstruction).
Compared with the Norwood procedure with an mBTS, the Norwood procedure with an RVPA conduit prevents diastolic steal and usually enables better coronary perfusion and improved stable hemodynamic status in the postoperative period. Although survival is better at 12 months with the RVPA conduit (74% vs 64% for the mBTS), mortality rates were similar to those associated with the mBTS beyond 1 year, 7 and the longterm effects of a ventriculotomy associated with an RVPA conduit remain unknown. Providing postoperative care to patients after the Norwood procedure is a challenge. Further research should focus on improving care processes that decrease morbidity and mortality in patients undergoing the Norwood operation. mortality, as previously noted by Tabbutt et al, 14 as well as intermediate-term and interstage mortality, echocardiographic data, neurodevelopmental outcomes, and 3-year follow-up.
In a secondary study of the data from the trial, Tweddell et al 57 found that lower socioeconomic status, obstructed pulmonary venous return, smaller ascending aorta, certain anatomical variations of HLHS, and diagnosis other than HLHS were associated with early-phase risk factors of mortality, predominantly within the first 12 months. Anatomical variations of HLHS associated with early mortality included mitral atresia with aortic stenosis, and mitral stenosis associated with aortic atresia. In addition, constant-phase risk factors associated with deceased survival included genetic abnormalities and younger gestational age. 57 Improved survival was noted in full-term infants with aortic atresia who had an RVPA conduit and in premature neonates with a patent aortic valve who had an mBTS. 57 Decreased right ventricular function and diagnosis other than HLHS were associated with cardiac transplant. 57 Mortality after discharge following the Norwood procedure was 12% and was greater in the mBTS group regardless of whether postoperative atrioventricular valve regurgitation was absent or mild. 58 Other interstage risk factors included moderate or more than moderate atrioventricular valve regurgitation in both RVPA and mBTS groups, prematurity (< 37 weeks' gestation), Hispanic ethnicity, HLHS with mitral atresia or aortic atresia variant, and increased number of complications after an initial stage I palliation. 58 In a review of echocardiographic imaging of both RVPA and mBTS groups, Frommelt et al 59 found that right ventricular ejection fraction was less than 50% in both groups after the Norwood procedure during the first 14 months. Even though ejection fraction was greater in the RVPA group after the initial operation, it was still similar in both groups by 14 months. Neoaortic annulus area and flow, peak arch velocity, and systolic ejection times were initially lower for the RVPA group but were similar in both groups at 14 months. 59 Newburger et al 60 reported that at 14 months, survivors of the Norwood procedure with either shunt variation scored significantly lower than normal on the Psychomotor Development Index and the Mental Development Index. Lower than normal scores on neurodevelopmental evaluations were similar between the groups and Early transplant-free survival is greater with the Norwood procedure with the RVPA conduit rather than the Norwood procedure with the mBTS. Now that you've read the article, create or contribute to an online discussion about this topic using eLetters. Just visit www.ccnonline.org and select the article you want to comment on. In the full-text or PDF view of the article, click "Responses" in the middle column and then "Submit a response." 
